Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry

被引：0
作者：
Jamie L. Todd
Megan L. Neely
Robert Overton
Katey Durham
Mridu Gulati
Howard Huang
Jesse Roman
L. Kristin Newby
Kevin R. Flaherty
Richard Vinisko
Yi Liu
Janine Roy
Ramona Schmid
Benjamin Strobel
Christian Hesslinger
Thomas B. Leonard
Imre Noth
John A. Belperio
Scott M. Palmer
机构：
[1] Duke Clinical Research Institute,Division of Pulmonary and Critical Care Medicine
[2] Duke University Medical Center,undefined
[3] Boehringer Ingelheim Pharmaceuticals Inc.,undefined
[4] Yale School of Medicine,undefined
[5] Houston Methodist Hospital,undefined
[6] Jane and Leonard Korman Respiratory Institute,undefined
[7] Duke Clinical & Translational Science Institute,undefined
[8] University of Michigan,undefined
[9] Staburo GmbH,undefined
[10] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
[11] University of Virginia,undefined
[12] David Geffen School of Medicine at UCLA,undefined
来源：
Respiratory Research | / 20卷
关键词：
Interstitial lung diseases; Observational study; Proteome; Registries;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 96 条
[1]  
Raghu G(2018)Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline Am J Respir Crit Care Med 198 e44-e68
[2]  
Remy-Jardin M(2018)Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper Lancet Respir Med 6 138-153
[3]  
Myers JL(2014)Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2071-2082
[4]  
Lynch DA(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2083-2092
[5]  
Sverzellati N(2012)Peripheral blood biomarkers in idiopathic pulmonary fibrosis Transl Res 159 218-227
[6]  
Travis WD(2017)New strategies and challenges in lung proteomics and metabolomics. An official American Thoracic Society workshop report Ann Am Thorac Soc 14 1721-1743
[7]  
Richeldi L(2018)Proteomics: clinical and research applications in respiratory diseases Respirology 23 993-1003
[8]  
du Bois RM(2017)The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes Sci Rep 7 46560-824
[9]  
Raghu G(2017)iTRAQ-based proteomics reveals novel biomarkers for idiopathic pulmonary fibrosis PLoS One 12 788-470
[10]  
King TE(2016)Rationale for and design of the idiopathic pulmonary fibrosis-PRospective outcomes (IPF-PRO) registry BMJ Open Respir Res 3 458-969
12345678910